Disclosures for "Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Japan"
-
Dr. Matsumori has nothing to disclose.
-
Mr. Ikeda has nothing to disclose.
-
Dr. Kudo has nothing to disclose.
-
Dr. Ishikawa has received personal compensation for serving as an employee of Pfizer. Dr. Ishikawa has stock in Pfizer.
-
Dr. Hoshino has received personal compensation for serving as an employee of Pfizer.
-
Dr. Yoshimatsu has received personal compensation for serving as an employee of Pfizer R&D Japan.
-
Dr. Thiry has received personal compensation for serving as an employee of Pfizer. Dr. Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Thiry has stock in Pfizer. Dr. Thiry has stock in Biohaven Pharmaceuticals.
-
Dr. Arakawa has received personal compensation for serving as an employee of Pfizer. Dr. Arakawa has stock in Pfizer.
-
Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.
-
Dr. Sakai has nothing to disclose.
-
Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sawai. Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teijin. Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hedgcock MedTech. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Elli-Lilly Japan. The institution of Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi-Sankyo.